167 related articles for article (PubMed ID: 33085791)
1. Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signalling via interaction with Gli1.
Zhang F; Wang F; He J; Lian N; Wang Z; Shao J; Ding H; Tan S; Chen A; Zhang Z; Wang S; Zheng S
Br J Pharmacol; 2021 Jun; 178(11):2246-2265. PubMed ID: 33085791
[TBL] [Abstract][Full Text] [Related]
2. Commentary on "Re-regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signaling via interaction with Gli1".
Weiskirchen R
Br J Pharmacol; 2021 Jan; 178(2):378-380. PubMed ID: 33085773
[No Abstract] [Full Text] [Related]
3. Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A/HIF-1α transcriptional complex.
Wang F; Chen L; Kong D; Zhang X; Xia S; Liang B; Li Y; Zhou Y; Zhang Z; Shao J; Zheng S; Zhang F
Hepatology; 2024 Mar; 79(3):606-623. PubMed ID: 37733267
[TBL] [Abstract][Full Text] [Related]
4. Pinostilbene hydrate suppresses hepatic stellate cell activation via inhibition of miR-17-5p-mediated Wnt/β-catenin pathway.
Zhou G; Li C; Zhan Y; Zhang R; Lv B; Geng W; Zheng J
Phytomedicine; 2020 Dec; 79():153321. PubMed ID: 32919323
[TBL] [Abstract][Full Text] [Related]
5. Wnt3a-regulated TCF4/β-catenin complex directly activates the key Hedgehog signalling genes
Wang Y; Lin P; Wang Q; Zheng M; Pang L
Exp Ther Med; 2018 Sep; 16(3):2101-2107. PubMed ID: 30186446
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.
Vilaseca M; García-Calderó H; Lafoz E; Ruart M; López-Sanjurjo CI; Murphy MP; Deulofeu R; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
Liver Int; 2017 Jul; 37(7):1002-1012. PubMed ID: 28371136
[TBL] [Abstract][Full Text] [Related]
7. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
8. GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin Pathway.
Yaqoob U; Luo F; Greuter T; Jalan Sakrikar N; Sehrawat TS; Lu J; Hu X; Gao J; Kostallari E; Chen J; Arab JP; Martin-Mateos R; Cao S; Shah VH
Cell Mol Gastroenterol Hepatol; 2020; 10(3):545-559. PubMed ID: 32447051
[TBL] [Abstract][Full Text] [Related]
9. Physalin B attenuates liver fibrosis via suppressing LAP2α-HDAC1-mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation.
Zhu X; Ye S; Yu D; Zhang Y; Li J; Zhang M; Leng Y; Yang T; Luo J; Chen X; Zhang H; Kong L
Br J Pharmacol; 2021 Sep; 178(17):3428-3447. PubMed ID: 33864382
[TBL] [Abstract][Full Text] [Related]
10. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.
Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602
[TBL] [Abstract][Full Text] [Related]
11. β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation.
Ge WS; Wang YJ; Wu JX; Fan JG; Chen YW; Zhu L
Mol Med Rep; 2014 Jun; 9(6):2145-51. PubMed ID: 24691643
[TBL] [Abstract][Full Text] [Related]
12. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
[TBL] [Abstract][Full Text] [Related]
13. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
Yu F; Fan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
[TBL] [Abstract][Full Text] [Related]
14. Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α.
Zhang F; Lu S; He J; Jin H; Wang F; Wu L; Shao J; Chen A; Zheng S
Theranostics; 2018; 8(3):610-626. PubMed ID: 29344293
[No Abstract] [Full Text] [Related]
15. Canonical hedgehog signalling regulates hepatic stellate cell-mediated angiogenesis in liver fibrosis.
Zhang F; Hao M; Jin H; Yao Z; Lian N; Wu L; Shao J; Chen A; Zheng S
Br J Pharmacol; 2017 Mar; 174(5):409-423. PubMed ID: 28052321
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.
Akcora BÖ; Storm G; Bansal R
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):804-818. PubMed ID: 29217140
[TBL] [Abstract][Full Text] [Related]
19. Gandouling inhibits hepatic fibrosis in Wilson's disease through Wnt-1/β-catenin signaling pathway.
Cheng C; Wang Q; Huang Y; Xue Q; Wang Y; Wu P; Liao F; Miao C
J Ethnopharmacol; 2023 Jul; 311():116445. PubMed ID: 37015279
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 knockdown attenuates the ameliorative effects of ligustrazine on hepatic fibrosis by targeting hepatic stellate cell transdifferentiation.
Lu C; Xu W; Zhang F; Shao J; Zheng S
Toxicology; 2016 Jul; 365():35-47. PubMed ID: 27477297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
